Page last updated: 2024-10-23

bisoprolol and Aldosteronism

bisoprolol has been researched along with Aldosteronism in 1 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Research Excerpts

ExcerptRelevanceReference
"Patients with bilateral primary aldosteronism (PA) generally are treated with antihypertensive drugs, but optimal treatment for patients with complications due to refractory hypertension has not been established."1.91Unilateral adrenalectomy for a drug-resistant bilateral primary aldosteronism with heart failure: pathophysiology and surgical indication. ( Akaihata, H; Hata, J; Honda-Takinami, R; Hoshi, S; Kataoka, M; Kojima, Y; Matsuoka, K; Ogawa, S; Onagi, A; Sato, Y; Tanji, R, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hoshi, S1
Onagi, A1
Tanji, R1
Honda-Takinami, R1
Matsuoka, K1
Hata, J1
Sato, Y1
Akaihata, H1
Kataoka, M1
Ogawa, S1
Kojima, Y1

Other Studies

1 other study available for bisoprolol and Aldosteronism

ArticleYear
Unilateral adrenalectomy for a drug-resistant bilateral primary aldosteronism with heart failure: pathophysiology and surgical indication.
    BMC endocrine disorders, 2023, Nov-07, Volume: 23, Issue:1

    Topics: Adrenal Glands; Adrenalectomy; Aldosterone; Antihypertensive Agents; Bisoprolol; Eplerenone; Heart F

2023